BioSpace News Archive

Ironwood Pharmaceuticals, Inc. today announced the appointment of John Minardo as senior vice president, chief legal officer.

Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced today that medac, Medexus’ licensor for treosulfan, has received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) in response to its New Drug Application (NDA) for treosulfan.

Arbutus Biopharma Corporation announced that the Company will participate in a fireside chat at the Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 10, 2021 at 4:05 PM ET.

Rain Therapeutics Inc., (NasdaqGS: RAIN) a late-stage company developing precision oncology therapeutics, today announced it will report financial results for the second quarter that ended June 30, 2021 and highlights of recent progress, on Tuesday, August 10, 2021.

TRACON Pharmaceuticals announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the BTIG Virtual Biotechnology Conference on August 10, 2021 at 12:00pm Eastern Time.

Pliant Therapeutics, Inc. today announced its participation in the 2021 BTIG Virtual Biotechnology Conference to be held August 9 – 10, 2021.

Engrail Therapeutics™ today announced the close of a $32 million extension of its Series A financing round, which brings the total round to $64 million.

Infinity Pharmaceuticals, Inc. today announced the grant of an inducement stock option award and an inducement restricted stock unit award to Stephane Peluso, Ph.D.

Magenta Therapeutics, Inc., a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, announced that the company will participate in the following August investor conferences

Hancock Jaffe Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation status to the VenoValve®